Robinhood Markets, Inc. sold $3.1M of RVI

Robinhood Markets, Inc. sold 124,319 shares of Robinhood Ventures Fund I (RVI) at $24.77 ($3.08M total) on 2026-10-28.

Original reporting
SEC EDGAR · Robinhood Markets, Inc.
Published Oct 30, 2026, 9:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 9:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$RVI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale may prompt short sellers and could slightly depress the stock price in the short term.

02

Market read

A modest insider sell that could generate short‑term pressure on RHO.

03

What to watch

The insider retained a large stake (12.9M shares) indicating continued confidence.

Relevance 6/10Novelty 4/10Timing: post‑market filing on 2026‑10‑30

Background

Form 4 filings disclose insider transactions; a 10% owner selling shares is noteworthy but not uncommon.

Market effects

Minimal impact on the broader brokerage sector.

Limited to U.S. equity markets.

Low

Counterpoint

The sale could be a routine portfolio rebalancing, not a negative signal.

Key entities

  • Robinhood Markets, Inc.

    U.S. brokerage platform listed on NASDAQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDGLMedAI 8/10

BAKER BROS. ADVISORS LP (BAKER FELIX, BAKER JULIAN) purchased $35.0M of MDGL (indirect holdings)

BAKER BROS. ADVISORS LP purchased 91,806 indirectly-held shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at an average of $381.49 ($366.99–$396.61, $35.02M total) across 5 trades over 2026-11-04 to 2026-11-06. Filed jointly with Baker Bros. Advisors (GP) LLC (Director), BAKER FELIX (Director), BAKER JULIAN (Director), 667, L.P. (Director) and Baker Brothers Life Sciences LP (Director).